Vaccines

Demyelinating disorders

Exposure

IIV4

Hypersensitivity

Hives

Multiple Sclerosis

Deltoid

MMR

Rubella

Acute

Hepatitis B

Autism

Antibody

Side Effect

Lymphocytes

Virus

HPV4

Vaccine

Antiviral

Breakthrough infection

RV5

HAV

DTP

Smallpox

PPSV23

Tetanus

Pneumonia

Mucosal membranes

Asthma

LAIV

Inflammatory Bowel Disease (IBD)

Passive immunity

Teratogenic

Strain

Lupus

Erythema Multiforme

Immunization

MenACWY-D

Contraindication

Placebo

Haemophilus influenzae type b (Hib)

Immunity

Investigational vaccine

4vHPV

Arthralgia

RRV-TV

HPV

Crib or Cot Death

MenACWY-CRM

Outbreak

Disease

Polysaccharide vaccines

Crohn’s disease

JE-VC

Ty21a

Sudden Infant Death Syndrome (SIDS)

Prevalence

Association

DTaP

Hib-MenCY-TT

Febrile

Epidemic

MenB-4C

Diabetes

Attenuated vaccine

Antitoxin

Quarantine

Antibiotic

Live vaccine

Orchitis

ZOS

PPV23

Acellular vaccine

Adjuvant

MenB-FHbp

Influenza

Acquired Immune Deficiency Syndrome (AIDS)

HepA

Thimerosal

Variola

Vaccinia

Jaundice

Anthrax

Mumps

B cells

Waning Immunity

HPV2

Immune globulin

Intussusception

Poliomyelitis

Bacteria

IIV

Shingles

MCV4

Typhoid Fever

ViCPS

Susceptible

Hepatitis C

Neuritis

Recombinant

IIV3

HepB

PRP-OMP

PRP-T

OPV

Advisory Committee on Immunization Practices (ACIP)

PCV7

Anaphylaxis

Etiology

Booster shots

MMRV

Asymptomatic infection

Meningitis

Varicella

Guillain-Barre Syndrome (GBS)

Measles

Hepatitis E

TIV

Pandemic

Tdap

Virulence

Prodromal

Hepatitis A

Urticaria

JE-MB

Encephalopathy

Efficacy rate

IPV

TT

Macular

ROTA

Reye Syndrome

9vHPV

Active immunity

Pathogens

Precaution

RIV3

Petechiae

Meningoencephalitis

2vHPV

Memory Cell

MenB

Incubation period

Diphtheria

YF

Hepatitis D

Subclinical infection

DT

BCG

LAIV4